Overview Financials News + Filings
|
|
Cirius Therapeutics, Inc.
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 1.5 | 0.9 | |
| |
| Returns on Capital |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | 0.0 |
| Days payables outstanding | | 32.0 | 14.6 |
| Cash conversion cycle | 0.0 | -32.0 | -14.6 |
|